4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001193125-26-467330
Director sold 1,381,762 shares at an average $38.75 ($53,536,738)
- Director disposed of 3,036,758 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Gold Daniel Allen · Director
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Sale : show line 1 in the form | −79,461 | $39.17 | $3,112,487 | 13,609,705 | I |
| 2026-11-16 | Sale : show line 2 in the form | −550,280 | $39.17 | $21,554,468 | 1,042,200 | I |
| 2026-11-16 | Sale : show line 3 in the form | −18,927 | $38.99 | $737,964 | 13,590,778 | I |
| 2026-11-16 | Sale : show line 4 in the form | −131,073 | $38.99 | $5,110,536 | 911,127 | I |
| 2026-11-17 | Other disposition : show line 5 in the form | −2,635,169 | 5,806,259 | I | ||
| 2026-11-17 | Other disposition : show line 6 in the form | −15,969 | 13,574,809 | I | ||
| 2026-11-17 | Other disposition : show line 7 in the form | −385,620 | 525,507 | I | ||
| 2026-11-17 | Sale : show line 8 in the form | −75,716 | $38.24 | $2,895,380 | 13,499,093 | I |
| 2026-11-17 | Sale : show line 9 in the form | −525,507 | $38.24 | $20,095,388 | 0 | I |
| 2026-11-17 | Sale : show line 10 in the form | −798 | $38.24 | $30,516 | 5,805,461 | I |
| Open-market sales · 1,381,762 sh · avg $38.75 · $53,536,738 | ||||||
Loading xslF345X06/ownership.xml…